Differentiation of primary CNS lymphoma and glioblastoma using Raman spectroscopy and machine learning algorithms

Authors

  • Gilbert Georg Klamminger Saarland University Medical Center and Faculty of Medicine, Homburg, Germany; National Center of Pathology (NCP), Laboratoire national de santé (LNS), Dudelange, Luxembourg; Luxembourg Center of Neuropathology (LCNP), Dudelange, Luxembourg
  • Karoline Klein Saarland University Medical Center and Faculty of Medicine, Homburg, Germany; National Center of Neurosurgery, Centre Hospitalier de Luxembourg (CHL), Luxembourg, Luxembourg
  • Laurent Mombaerts Luxembourg Centre of Systems Biomedicine (LCSB), University of Luxembourg (UL), Esch-sur-Alzette, Luxembourg
  • Finn Jelke Saarland University Medical Center and Faculty of Medicine, Homburg, Germany; National Center of Neurosurgery, Centre Hospitalier de Luxembourg (CHL), Luxembourg, Luxembourg
  • Giulia Mirizzi Saarland University Medical Center and Faculty of Medicine, Homburg, Germany; National Center of Neurosurgery, Centre Hospitalier de Luxembourg (CHL), Luxembourg, Luxembourg
  • Rédouane Slimani Doctoral School in Science and Engineering (DSSE), University of Luxembourg (UL), Esch-sur-Alzette, Luxembourg; Department of Oncology (DONC), Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg
  • Andreas Husch Luxembourg Centre of Systems Biomedicine (LCSB), University of Luxembourg (UL), Esch-sur-Alzette, Luxembourg
  • Michel Mittelbronn National Center of Pathology (NCP), Laboratoire national de santé (LNS), Dudelange, Luxembourg; Luxembourg Center of Neuropathology (LCNP), Dudelange, Luxembourg; Luxembourg Centre of Systems Biomedicine (LCSB), University of Luxembourg (UL), Esch-sur-Alzette, Luxembourg; Department of Oncology (DONC), Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg; Department of Life Sciences and Medicine (DLSM), University of Luxembourg, Esch-sur-Alzette, Luxembourg; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg
  • Frank Hertel Saarland University Medical Center and Faculty of Medicine, Homburg, Germany; National Center of Neurosurgery, Centre Hospitalier de Luxembourg (CHL), Luxembourg, Luxembourg; Luxembourg Centre of Systems Biomedicine (LCSB), University of Luxembourg (UL), Esch-sur-Alzette, Luxembourg
  • Felix Bruno Kleine Borgmann Luxembourg Center of Neuropathology (LCNP), Dudelange, Luxembourg; Luxembourg Centre of Systems Biomedicine (LCSB), University of Luxembourg (UL), Esch-sur-Alzette, Luxembourg; Department of Oncology (DONC), Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg

DOI:

https://doi.org/10.17879/freeneuropathology-2021-3458

Keywords:

Raman spectroscopy, PCNSL, Glioblastoma, Machine learning

Abstract

Objective and Methods:

Timely discrimination between primary CNS lymphoma (PCNSL) and glioblastoma is crucial for diagnostics and therapy, but most importantly also determines the intraoperative surgical course. Advanced radiological methods allow this to a certain extent but ultimately, biopsy is still necessary for final diagnosis. As an upcoming method that enables tissue analysis by tracking changes in the vibrational state of molecules via inelastic scattered photons, we used Raman Spectroscopy (RS) as a label free method to examine specimens of both tumor entities intraoperatively, as well as postoperatively in formalin fixed paraffin embedded (FFPE) samples.

Results:

We applied and compared statistical performance of linear and nonlinear machine learning algorithms (Logistic Regression, Random Forest and XGBoost), and found that Random Forest classification distinguished the two tumor entities with a balanced accuracy of 82,4% in intraoperative tissue condition and with 94% using measurements of distinct tumor areas on FFPE tissue. Taking a deeper insight into the spectral properties of the tumor entities, we describe different tumor-specific Raman shifts of interest for classification.

Conclusions:

Due to our findings, we propose RS as an additional tool for fast and non-destructive, perioperative tumor tissue discrimination, which may augment treatment options at an early stage. RS may further serve as a useful additional tool for neuropathological diagnostics with little requirements for tissue integrity.

Metrics

Metrics Loading ...

Downloads

Additional Files

Published

2021-10-04

How to Cite

Klamminger, G. G., Klein, K., Mombaerts, L., Jelke, F., Mirizzi, G., Slimani, R., Husch, A., Mittelbronn, M., Hertel, F., & Kleine Borgmann, F. B. (2021). Differentiation of primary CNS lymphoma and glioblastoma using Raman spectroscopy and machine learning algorithms. Free Neuropathology, 2, 26. https://doi.org/10.17879/freeneuropathology-2021-3458

Issue

Section

Original Papers